Alpha-synuclein propagation: New insights from animal models

被引：96
|
作者：
Dehay, Benjamin [1 ,2 ]
Vila, Miquel [3 ,4 ,5 ]
Bezard, Erwan [1 ,2 ]
Brundin, Patrik [6 ]
Kordower, Jeffrey H. [7 ]
机构：
[1] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33076 Bordeaux, France
[2] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France
[3] Vall dHebron Res Inst, Neurodegenerat Dis Res Grp, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain
[4] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain
[5] Catalan Inst Res & Adv Studies, Barcelona, Spain
[6] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Translat Parkinsons Dis Res, Grand Rapids, MI USA
[7] Rush Univ, Dept Neurol Sci, Grad Coll, Chicago, IL 60612 USA
来源：
MOVEMENT DISORDERS | 2016年 / 31卷 / 02期
关键词：
alpha-synuclein; propagation; synucleinopathy; Parkinson's disease; animal models; MULTIPLE SYSTEM ATROPHY; TO-NEURON TRANSMISSION; PARKINSONS-DISEASE; TRANSGENIC MICE; INCLUSION FORMATION; PATHOLOGY SPREAD; MUTATION; BRAIN; OLIGOMERS; FIBRILS;
D O I：
10.1002/mds.26370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Aggregation of alpha-synuclein is implicated in several neurodegenerative diseases collectively termed synucleinopathies. Emerging evidence strongly implicates cell-to-cell transmission of misfolded alpha-synuclein as a common pathogenetic mechanism in synucleinopathies. The impact of alpha-synuclein pathology on neuronal dysfunction and behavioral impairments is being explored in animal models. This review provides an update on how research in animal models supports the concept that misfolded alpha-synuclein spreads from cell to cell and describes how findings in animal models might relate to the disease process in humans. Finally, we discuss the current underlying molecular and cellular mechanisms and future therapeutic strategies targeting alpha-synuclein propagation. (c) 2015 International Parkinson and Movement Disorder Society
引用
收藏
页码：161 / 168
页数：8
相关论文
共 50 条
  • [1] Alpha-Synuclein Animal Models
    Aebischer, P.
    MOVEMENT DISORDERS, 2010, 25 : S606 - S606
  • [2] In vivo models of alpha-synuclein transmission and propagation
    Ariadna Recasens
    Ayse Ulusoy
    Philipp J. Kahle
    Donato A. Di Monte
    Benjamin Dehay
    Cell and Tissue Research, 2018, 373 : 183 - 193
  • [3] In vivo models of alpha-synuclein transmission and propagation
    Recasens, Ariadna
    Ulusoy, Ayse
    Kahle, Philipp J.
    Di Monte, Donato A.
    Dehay, Benjamin
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 183 - 193
  • [4] Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models
    Petrucci, Simona
    Ginevrino, Monia
    Valente, Enza Maria
    PARKINSONISM & RELATED DISORDERS, 2016, 22 : S16 - S20
  • [5] Passive Immunization in Alpha-Synuclein Preclinical Animal Models
    Folke, Jonas
    Ferreira, Nelson
    Brudek, Tomasz
    Borghammer, Per
    Van Den Berge, Nathalie
    BIOMOLECULES, 2022, 12 (02)
  • [6] New insights into the mechanism of amyloid formation by alpha-synuclein
    Buell, A. K.
    Galvagnion, C.
    Dobson, C. M.
    Knowles, T. P. J.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S100 - S100
  • [7] Propagation of pathologic alpha-synuclein from kidney to brain
    Chen, L.
    Yuan, X.
    Nie, S.
    Zhang, Z.
    BRAIN PATHOLOGY, 2023, 33
  • [8] Transcriptional regulation of alpha-synuclein: insights from blood?
    Chesselet, Marie-Francoise
    Ritz, Beate
    FUTURE NEUROLOGY, 2009, 4 (02) : 145 - 147
  • [9] Alpha-Synuclein: a new evidence?
    Meissner, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 891 - 891
  • [10] Alpha-synuclein and transgenic mouse models
    Fernagut, PO
    Chesselet, MF
    NEUROBIOLOGY OF DISEASE, 2004, 17 (02) : 123 - 130
12345